Showing 321-330 of 20328 results for "".
Digital Innovation in Diabetes Prevention for Older Adults
https://reachmd.com/programs/diabetes-discourse/digital-diabetes-prevention/57028/Can older adults successfully engage with telehealth, wearable technology, and digital health tools to prevent type 2 diabetes? In this conversation with Dr. Steve Jackson, Dr. Emily Johnston and Dr. Souptik Barua discuss emerging insights on how these strategies could improve accessibility and engaThe Importance of Diabetes Education for Patients and Providers
https://reachmd.com/programs/diabetes-discourse/the-importance-of-diabetes-education-for-patients-and-providers/4846/The results of the landmark Diabetes Control and Complications Trial proved that intensive management of diabetes can significantly improve diabetes outcomes. The education of both the healthcare professional and patient is a key component in the successful management of diabetes. Join host Dr. StevRethinking Diabetes Care: Key Data from Incorporating Lifestyle Modifications
https://reachmd.com/programs/medical-industry-feature/rethinking-diabetes-care-key-data-from-incorporating-lifestyle-modifications/14289/What role do lifestyle modifications have in managing obesity and type 2 diabetes? Find out.Balancing Blood Sugar: The Role of Yoga in Diabetes Management
https://reachmd.com/programs/what-your-patients-are-talking-about/tbd/15490/Tune in to find out how yoga can help lower blood sugar levels in patients with type 2 diabetes.Obesity, Diabetes and the Metabolic Syndrome
https://reachmd.com/programs/lipid-luminations/obesity-diabetes-and-the-metabolic-syndrome/6706/Host Dr. Alan S. Brown is joined by Kevin C. Maki, PhD, FNLA, Chief Science Officer of Biofortis Clinical Research. Dr. Maki will review obesity, metabolic syndrome and type 2 diabetes mellitus as they are all insulin resistant states and are often characterized by atherogenic dyslipidemia or theThe Diabetes Infrastructure: Regulation & Reimbursement
https://reachmd.com/programs/diabetes-discourse/the-diabetes-infrastructure-regulation-reimbursement/4796/The prevalence of diabetes complications and its associated costs represent an infrastructure that may be virtually unsustainable in the near future. Join host Dr. Steven Edelman and his guest, editor-in-chief of the diabetes publications Closer Look and Diabetes Close Up, Kelly Close, as they discuCurrent Trends and Treatment Goals for Diabetes
https://reachmd.com/programs/focus-on-pharmacy/current-trends-and-treatment-goals-for-diabetes/3531/How can we best optimize pharmacotherapy for patients with Type 2 diabetes? What are the main treatment barriers to keep in mind, and what are the most common comorbidities that we might be able to treat concurrently with diabetes therapy? Dr. Susan Cornell, assistant professor of pharmacy practiceWhat Type 2 Inflammation in COPD Means for Treatment Decision Making
https://reachmd.com/programs/deep-breaths-updates-chest/type-2-inflammation-copd-treatment-decisions/36159/COPD is increasingly recognized as a heterogeneous disease, and for a subset of patients, type 2 inflammation plays a meaningful role in exacerbation risk and treatment response. Given that, Drs. Stephanie Christenson and Diego Maselli come together to examine how insights into the pathobiology of tThe Link Between Diabetes and Sleep Apnea
https://reachmd.com/programs/diabetes-discourse/the-link-between-diabetes-and-sleep-apnea/4601/Type 2 diabetes and obstructive sleep apnea have been shown to have a close relationship. Join host Dr. Steven Edelman and his guest, sleep specialist and pulmonologist Dr. Shazia Jamil, as they discuss the diagnosis and treatments of obstructive sleep apnea including continuous positive airway presDo Women With Diabetes Have a Greater Risk of Cardiovascular Disease?
https://reachmd.com/programs/diabetes-discourse/do-women-with-diabetes-have-a-greater-risk-of-cardiovascular-disease/5946/What is known about the relationship between glucose control and cardiovascular disease in diabetes? The recent Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial provides some interesting results on the relationship between type 2 diabetes and silent m